Skip to main content
. 2022 Dec 20;12:993611. doi: 10.3389/fonc.2022.993611

Figure 1.

Figure 1

Kaplan-Meier estimates of 39 patients from the AVETUX trial for PFS (A) and OS (B). Number of patients at specific timepoints are indicated. Median PFS or OS is depicted. (C) Best response achieved and confirmed in radiological review is presented. Secondary resection, chemotherapy only, stable disease, partial remission, no evidence of disease (after resection) or complete remission is indicated.